Agilent Technologies (NYSE:A) Price Target Raised to $175.00

Agilent Technologies (NYSE:A) had its target price boosted by Morgan Stanley from $160.00 to $175.00 in a research report released on Wednesday,Benzinga reports. Morgan Stanley currently has an overweight rating on the medical research company’s stock.

A has been the topic of a number of other research reports. Robert W. Baird lifted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. Wells Fargo & Company reduced their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Finally, Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price target for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Stock Down 0.5%

Shares of Agilent Technologies stock opened at $148.55 on Wednesday. The company has a market cap of $41.95 billion, a P/E ratio of 29.83, a PEG ratio of 2.64 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies has a one year low of $108.35 and a one year high of $160.27. The firm has a fifty day moving average of $135.38 and a two-hundred day moving average of $125.56.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the previous year, the firm earned $1.31 earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts forecast that Agilent Technologies will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Institutional Investors Weigh In On Agilent Technologies

Several institutional investors and hedge funds have recently made changes to their positions in A. SHP Wealth Management purchased a new position in Agilent Technologies during the 4th quarter valued at about $26,000. Core Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at about $26,000. Navalign LLC purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at about $27,000. MV Capital Management Inc. acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $28,000. Finally, Entrust Financial LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $31,000.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.